Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Ductal Carcinoma In Situ
Interventions: OTHER: Laboratory Biomarker Analysis|BIOLOGICAL: Trastuzumab|RADIATION: Whole Breast Irradiation
Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology